Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China flag China · Delayed Price · Currency is CNY
34.19
+1.92 (5.95%)
At close: Mar 6, 2026

SHA:688062 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
662.52199.62127.6827.615.88
Other Revenue
-0.160.150.130.35
662.52199.78127.8427.7316.23
Revenue Growth (YoY)
231.62%56.28%361.03%70.88%206.03%
Cost of Revenue
-34.487.32.015.22
Gross Profit
662.52165.3120.5325.7211
Selling, General & Admin
-405.2368.36267.62189.16
Research & Development
-782.87835.78758.61622.51
Other Operating Expenses
1,6194.423.81.880.8
Operating Expenses
1,6191,1931,2081,028812.44
Operating Income
-956.16-1,027-1,087-1,002-801.44
Interest Expense
--57.78-13.35-10.3-6.41
Interest & Investment Income
-20.9246.8845.757.38
Currency Exchange Gain (Loss)
-0.28-0.010.16-0.24
Other Non Operating Income (Expenses)
-1.08-2.34-1.74-1.822.63
EBT Excluding Unusual Items
-957.24-1,066-1,056-968.59-798.07
Gain (Loss) on Sale of Investments
--3.73-4.691.08-0.23
Gain (Loss) on Sale of Assets
--0.11-0.010.332.06
Asset Writedown
---3.56--
Other Unusual Items
-22.58.619.0623.54
Pretax Income
-957.24-1,047-1,055-958.13-772.7
Income Tax Expense
12.94-0.913.52--
Earnings From Continuing Operations
-970.18-1,047-1,059-958.13-772.7
Minority Interest in Earnings
-2.655.382.893.11
Net Income
-970.18-1,044-1,053-955.23-769.59
Net Income to Common
-970.18-1,044-1,053-955.23-769.59
Shares Outstanding (Basic)
399400399391299
Shares Outstanding (Diluted)
399400399391299
Shares Change (YoY)
-0.18%0.24%1.93%30.74%5.32%
EPS (Basic)
-2.43-2.61-2.64-2.44-2.57
EPS (Diluted)
-2.43-2.61-2.64-2.44-2.57
Free Cash Flow
--1,287-1,283-1,264-639.91
Free Cash Flow Per Share
--3.22-3.21-3.23-2.14
Gross Margin
100.00%82.74%94.29%92.75%67.81%
Operating Margin
-144.32%-514.17%-850.65%-3615.06%-4939.16%
Profit Margin
-146.44%-522.53%-824.05%-3445.00%-4742.85%
Free Cash Flow Margin
--643.96%-1003.35%-4559.01%-3943.69%
EBITDA
-859.31-930.36-1,013-937.96-739.4
EBITDA Margin
-129.70%----
D&A For EBITDA
96.8596.8574.4364.4362.04
EBIT
-956.16-1,027-1,087-1,002-801.44
EBIT Margin
-144.32%----
Revenue as Reported
-199.78127.8427.7316.23
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.